Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics

Neurobiology of Disease

Volumn 78, Issue , 2015, Pages 45-55

  Rao, Shailaja Kishan ^a   Ross, Jordan M ^a   Harrison, Fiona E ^b,c   Bernardo, Alexandra ^c,d   Reiserer, Randall S ^c   Reiserer, Ronald S ^b   Mobley, James A ^e   McDonald, Michael P ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^e University of Alabama at Birmingham   (United States)

Author keywords

Alzheimer's disease; Amyloid; Behavior; Cognition; Exercise; Memory

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; PRESENILIN 1; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; PSEN1 PROTEIN, HUMAN; SECRETASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITION; CYTOSKELETON; EXERCISE; HIPPOCAMPUS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RUNNING; SITTING; SPATIAL MEMORY; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; WILD TYPE; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BEHAVIOR, ANIMAL; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PRESENILIN-1; PROTEOMICS; SPATIAL MEMORY;

EID: 84926483041     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.03.018     Document Type: Article

References (62)

1. Adlard P.A., Perreau V.M., Pop V., Cotman C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 2005, 25:4217-4221.
2. Ariga T., McDonald M.P., Yu R.K. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease. J. Lipid Res. 2008, 49:1157-1175.
3. Ariga T., Yanagisawa M., Wakade C., Ando S., Buccafusco J.J., McDonald M.P., Yu R.K. Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain. ASN Neuro. 2010, 2.
4. Ariga T., Itokazu Y., McDonald M.P., Hirabayashi Y., Ando S., Yu R.K. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα. ASN Neuro. 2013, 5:141-148.
5. Arrazola M.S., Varela-Nallar L., Colombres M., Toledo E.M., Cruzat F., Pavez L., Assar R., Aravena A., Gonzalez M., Montecino M., Maass A., Martinez S., Inestrosa N.C. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/β-catenin signaling pathway. J. Cell. Physiol. 2009, 221:658-667.
6. Bazalakova M.H., Wright J., Schneble E.J., McDonald M.P., Heilman C.J., Levey A.I., Blakely R.D. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav. 2007, 6:411-424.
7. Bernardo A., McCord M., Troen A.M., Allison J.D., McDonald M.P. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol. Aging 2007, 28:1195-1205.
8. Bernardo A., Harrison F.E., McCord M., Zhao J., Bruchey A., Davies S.S., Jackson Roberts L., Mathews P.M., Matsuoka Y., Ariga T., Yu R.K., Thompson R., McDonald M.P. Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice. Neurobiol. Aging 2009, 30:1777-1791.
9. Biscaro B., Lindvall O., Hock C., Ekdahl C.T., Nitsch R.M. Aβ immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice. J. Neurosci. 2009, 29:14108-14119.
10. Biscaro B., Lindvall O., Tesco G., Ekdahl C.T., Nitsch R.M. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener. Dis. 2012, 9:187-198.
11. Blass J.P. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann. N. Y. Acad. Sci. 2000, 924:170-183.
12. Caccamo A., Maldonado M.A., Bokov A.F., Majumder S., Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:22687-22692.
13. Calafiore M., Battaglia G., Zappala A., Trovato-Salinaro E., Caraci F., Caruso M., Vancheri C., Sortino M.A., Nicoletti F., Copani A. Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to β-amyloid. Neurobiol. Aging 2006, 27:606-613.
14. Cao D., Lu H., Lewis T.L., Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 2007, 282:36275-36282.
15. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 2002, 33:562-571.
16. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 2003, 85:1394-1401.
17. Cohen E., Paulsson J.F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H.M., Holzenberger M., Kelly J.W., Masliah E., Dillin A. Reduced IGF-1 signaling delays age- associated proteotoxicity in mice. Cell 2009, 139:1157-1169.
18. Cuadrado-Tejedor M., Vilarino M., Cabodevilla F., Del Rio J., Frechilla D., Perez-Mediavilla A. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β. J. Alzheimers Dis. 2011, 23:195-206.
19. D'Alton S., George D.R. Changing perspectives on Alzheimer's disease: thinking outside the amyloid box. J. Alzheimers Dis. 2011, 25:571-581.
20. Dhanushkodi A., McDonald M.P. Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration. PLoS One 2011, 6:e29285.
21. Dineley K.T., Kayed R., Neugebauer V., Fu Y., Zhang W., Reese L.C., Taglialatela G. Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J. Neurosci. Res. 2010, 88:2923-2932.
22. Flanigan T.J., Xue Y., Kishan Rao S., Dhanushkodi A., McDonald M.P. Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. Genes Brain Behav. 2014, 13:488-500.
23. Giuffrida M.L., Caraci F., Pignataro B., Cataldo S., De Bona P., Bruno V., Molinaro G., Pappalardo G., Messina A., Palmigiano A., Garozzo D., Nicoletti F., Rizzarelli E., Copani A. β-amyloid monomers are neuroprotective. J. Neurosci. 2009, 29:10582-10587.
24. Hamilton A., Holscher C. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(δE9) mouse model of Alzheimer's disease. Brain Res. 2012, 1449:83-93.
25. Harrison F.E., Allard J., Bixler R., Usoh C., Li L., May J.M., McDonald M.P. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr. Neurosci. 2009, 12:203-218.
26. Harrison F.E., Hosseini A.H., McDonald M.P., May J.M. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol. Biochem. Behav. 2009, 93:443-450.
27. Harrison F.E., May J.M., McDonald M.P. Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice. Pharmacol. Biochem. Behav. 2010, 94:543-552.
28. He N., Jin W.L., Lok K.H., Wang Y., Yin M., Wang Z.J. Amyloid-β(1-42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2. Cell Death Dis. 2013, 4:e924.
29. Heo C., Chang K.A., Choi H.S., Kim H.S., Kim S., Liew H., Kim J.A., Yu E., Ma J., Suh Y.H. Effects of the monomeric, oligomeric, and fibrillar Aβ42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zone. J. Neurochem. 2007, 102:493-500.
30. Hu Y.S., Long N., Pigino G., Brady S.T., Lazarov O. Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling. PLoS One 2013, 8:e64460.
31. Hur J.Y., Teranishi Y., Kihara T., Yamamoto N.G., Inoue M., Hosia W., Hashimoto M., Winblad B., Frykman S., Tjernberg L.O. Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain. J. Biol. Chem. 2012, 287:11991-12005.
32. Jin K., Galvan V., Xie L., Mao X.O., Gorostiza O.F., Bredesen D.E., Greenberg D.A. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13363-13367.
33. Kamphuis W., Orre M., Kooijman L., Dahmen M., Hol E.M. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia 2012, 60:615-629.
34. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54:111-118.
35. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74:5383-5392.
36. Klyubin I., Walsh D.M., Lemere C.A., Cullen W.K., Shankar G.M., Betts V., Spooner E.T., Jiang L., Anwyl R., Selkoe D.J., Rowan M.J. Amyloidβ protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 2005, 11:556-561.
37. Lazarov O., Marr R.A. Neurogenesis and Alzheimer's disease: at the crossroads. Exp. Neurol. 2010, 223:267-281.
38. Lewis T.L., Cao D., Lu H., Mans R.A., Su Y.R., Jungbauer L., Linton M.F., Fazio S., LaDu M.J., Li L. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. J. Biol. Chem. 2010, 285:36958-36968.
39. Li X., Guo F., Zhang Q., Huo T., Liu L., Wei H., Xiong L., Wang Q. Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice. BMC Complement. Altern. Med. 2014, 14:37.
40. López-Toledano M.A., Shelanski M.L. Neurogenic effect of β-amyloid peptide in the development of neural stem cells. J. Neurosci. 2004, 24:5439-5444.
41. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Hayashida N., Asada-Utsugi M., Watanabe K., Uemura M., Kihara T., Takahashi R., Shimohama S., Kinoshita A. Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J. Biol. Chem. 2012, 287:23024-23033.
42. Maesako M., Uemura K., Iwata A., Kubota M., Watanabe K., Uemura M., Noda Y., Asada-Utsugi M., Kihara T., Takahashi R., Shimohama S., Kinoshita A. Continuation of exercise is necessary to inhibit high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. PLoS One 2013, 8:e72796.
43. Marcello E., Gardoni F., Mauceri D., Romorini S., Jeromin A., Epis R., Borroni B., Cattabeni F., Sala C., Padovani A., Di Luca M. Synapse-associated protein-97 mediates α-secretase ADAM10 trafficking and promotes its activity. J. Neurosci. 2007, 27:1682-1691.
44. Masliah E., Westland C.E., Rockenstein E.M., Abraham C.R., Mallory M., Veinberg I., Sheldon E., Mucke L. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 1997, 78:135-146.
45. Miyakawa T., Yamada M., Duttaroy A., Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 2001, 21:5239-5250.
46. Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C.R. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 1994, 666:151-167.
47. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75:4646-4658.
48. Niidome T., Taniuchi N., Akaike A., Kihara T., Sugimoto H. Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice. Neuroreport 2008, 19:1361-1364.
49. O'Nuallain B., Klyubin I., Mc Donald J.M., Foster J.S., Welzel A., Barry A., Dykoski R.K., Cleary J.P., Gebbink M.F., Rowan M.J., Walsh D.M. A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ. J. Neurochem. 2011, 119:189-201.
50. Ramirez C.M., Gonzalez M., Diaz M., Alonso R., Ferrer I., Santpere G., Puig B., Meyer G., Marin R. VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol. Cell. Neurosci. 2009, 42:172-183.
51. Reddy P.H. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?. Biochim. Biophys. Acta 2013, 1832:67-75.
52. Swe+PSEN1δE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav. 2007, 6:54-65.
53. Sampson M.J., Lovell R.S., Davison D.B., Craigen W.J. A novel mouse mitochondrial voltage-dependent anion channel gene localizes to chromosome 8. Genomics 1996, 36:192-196.
54. Scopes D.I., O'Hare E., Jeggo R., Whyment A.D., Spanswick D., Kim E.M., Gannon J., Amijee H., Treherne J.M. A oligomer toxicity inhibitor protects memory in models of synaptic toxicity. Br. J. Pharmacol. 2012, 167:383-392.
55. Selkoe D.J. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192:106-113.
56. Sotthibundhu A., Li Q.X., Thangnipon W., Coulson E.J. Aβ(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor. Neurobiol. Aging 2009, 30:1975-1985.
57. Taniuchi N., Niidome T., Goto Y., Akaike A., Kihara T., Sugimoto H. Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice. Neuroreport 2007, 18:1801-1805.
58. Toledo E.M., Inestrosa N.C. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1δE9 mouse model of Alzheimer's disease. Mol. Psychiatry 2010, 15:272-285. (228).
59. Weatherly D.B., Atwood J.A., Minning T.A., Cavola C., Tarleton R.L., Orlando R. A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol. Cell. Proteomics 2005, 4:762-772.
60. Winner B., Kohl Z., Gage F.H. Neurodegenerative disease and adult neurogenesis. Eur. J. Neurosci. 2011, 33:1139-1151.
61. Yoo B.C., Fountoulakis M., Cairns N., Lubec G. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis 2001, 22:172-179.
62. Zheng M., Liu J., Ruan Z., Tian S., Ma Y., Zhu J., Li G. Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain. Amyloid 2013, 20:13-20.